Forefront Lecture by Dr. Anne Spaulding

“HIV in Jail Populations”

Anne Spaulding, MD, MPH, is a Research Assistant Professor in the Department of Epidemiology at Rollins School of Public Health, Emory University. She entered the field of correctional health in 1996 when she was appointed the medical program director for the Rhode Island Department of Corrections, a combined jail and prison. Her specific interests are infectious and chronic disease epidemiology in correctional and drug-using populations. Current projects include leading a national evaluation and support center for jails instituting rapid HIV testing and conducting a study of issues facing the HIV infected inmate returning to the community after serving time in Georgia state prisons. Her clinical work focuses on treating HCV and HIV infected incarcerated women.


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below